2m 2m 2m 2m 2m 2m 2m
APIMEDS PHARMA (APUS)
NYSE
$4.92-$0.24 (-4.56%)
Price as of Aug 03, 2026 4:10 PM EDT- $7.8MMarket Cap
- -70.40%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
APIMEDS PHARMA (APUS)
$4.92-$0.24 (-4.56%)
APUS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.15 | ||
Change | +$0.23 (+4.67%) | ||
Open | $4.77 | ||
High | $6.15 | ||
Low | $4.15 | ||
Previous Close | $4.92 | ||
Volume | 55,748 | ||
30-Day Average Volume | 41,692 | ||
1-Week Change | -8.85% | ||
1-Month Change | -42.78% | ||
1-Year Change | -70.40% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.5M | ||
Total Assets | $141.2M | ||
Market Cap | $7.8M | ||
Enterprise Value | $15.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$35.1M | ||
Free Cash Flow | -$2.1M | ||
EBIT | -$35.1M | ||
EBITDA | -$35.0M | ||
Net Working Capital | -$1.4M | ||
EPS | -$22.60 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/24/2026 | ||
Earnings & Revenue